Translate page

iStock 1203771991 CoronavirusIn this ever changing COVID-19 (coronavirus) pandememic keeping up to date with reliable information is key. In an effort to serve the CML community best during these difficult times, we have created this COVID-19 hub to provide you with expert statements, frequenty asked questions, relevant clinical papers and other reliable ressources.

We will be keeping you updated as more information becomes available.

If you have specific questions or want to share information around COVID-19 and CML that has been particularly helpful to you, please email

Questions about CML management during the COVID-19 pandemic remain highly relevant for clinical practice. In particular, whether COVID-19 vaccines are recommended and effective for people with CML.

To provide you with the best possible support, the iCMLf continues to update our COVID-19 Hub with CML specific information on COVID-19. We are also sharing an updated statement on COVID-19 vaccines for people with CML. You can read the full statement below

The iCMLf has compiled for you expert talks, frequently asked questions, statements, expert opinions and interesting cases on COVID-19 and CML from reliable sources.

On this section you will find statements, expert talks and frequently asked questions about COVID-19 vaccines and CML.

To help physicians confidently treat people with CML during the pandemic, the iCMLf has collected and analysed COVID-19 cases among patients with CML globally.

With over 1,000 cases reported by >190 physicians from 59 countries the iCMLf CANDID study represents the largest cohort of CML patients with COVID-19 aiming to collect and analyse characteristics of COVID-19 cases among CML patients globally.

The iCMLf is sharing a selection of interesting scientific publications on COVID-19 and CML from peer-reviewed journals.